semaglutide vs tirzepatide microdosing difference Semaglutide vs Tirzepatide, which is better for you? Semaglutide vs. Tirzepatide for weight

A study of more than 110,000 women found those who took popular GLP-1 drugs prescribed for obesity or diabetes had a lower risk of breast cancer.

Learn what science says about mood changes, anxiety, and emotional flatness.

Phase 3 data shows up to 71 lb lost in 68 weeks

HPLC-verified, third-party tested research compound

As a result, there has been a recent movement to create and use analogues that manipulate these gut hormones to support weight loss

Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection